Volume 42, Issue 3, Pages (March 2015)

Slides:



Advertisements
Similar presentations
Volume 19, Issue 5, Pages (May 2017)
Advertisements

Volume 8, Issue 4, Pages (April 2017)
Volume 144, Issue 3, Pages e1 (March 2013)
M. Fu, G. Huang, Z. Zhang, J. Liu, Z. Zhang, Z. Huang, B. Yu, F. Meng 
Volume 44, Issue 1, Pages (January 2016)
Volume 2, Issue 2, Pages (February 2016)
Volume 21, Issue 11, Pages (December 2017)
Volume 21, Issue 11, Pages (December 2017)
Volume 2, Issue 3, Pages (March 2016)
Volume 4, Issue 4, Pages e5 (April 2017)
Repeated FcεRI triggering reveals modified mast cell function related to chronic allergic responses in tissue  Jolien Suurmond, MSc, Kim L.L. Habets,
Volume 24, Issue 1, Pages (July 2016)
Volume 138, Issue 4, Pages (August 2009)
Volume 21, Issue 11, Pages (December 2017)
Volume 33, Issue 1, Pages (July 2010)
Volume 11, Issue 2, Pages (August 2012)
Volume 23, Issue 11, Pages (June 2018)
Learning More from Microarrays: Insights from Modules and Networks
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 22, Issue 5, Pages (November 2015)
Volume 26, Issue 3, Pages e5 (September 2017)
Volume 24, Issue 5, Pages (November 2016)
Volume 17, Issue 10, Pages (October 2010)
Volume 1, Issue 4, Pages (October 2015)
Volume 45, Issue 3, Pages (February 2012)
Revealing Global Regulatory Perturbations across Human Cancers
Volume 5, Issue 1, Pages e4 (July 2017)
Volume 153, Issue 1, Pages (March 2013)
Transcriptional Landscape of Cardiomyocyte Maturation
Volume 24, Issue 8, Pages (August 2018)
Christian M. Metallo, Matthew G. Vander Heiden  Molecular Cell 
The Translational Landscape of the Mammalian Cell Cycle
Volume 7, Issue 3, Pages (May 2014)
Dynamic Gene Regulatory Networks of Human Myeloid Differentiation
Volume 1, Issue 2, Pages (August 2015)
Lea Goentoro, Marc W. Kirschner  Molecular Cell 
Volume 20, Issue 5, Pages e7 (May 2017)
Volume 47, Issue 3, Pages e3 (September 2017)
Volume 36, Issue 1, Pages (January 2012)
Volume 21, Issue 11, Pages (December 2017)
John Smestad, Luke Erber, Yue Chen, L. James Maher
Volume 44, Issue 6, Pages (June 2016)
Revealing Global Regulatory Perturbations across Human Cancers
Volume 24, Issue 1, Pages (July 2016)
Volume 16, Issue 7, Pages (August 2016)
Michal Levin, Tamar Hashimshony, Florian Wagner, Itai Yanai 
Volume 23, Issue 3, Pages (March 2016)
Shiran Bar, Maya Schachter, Talia Eldar-Geva, Nissim Benvenisty 
Volume 37, Issue 6, Pages (December 2012)
A Broken Krebs Cycle in Macrophages
Volume 24, Issue 3, Pages (September 2016)
Volume 35, Issue 2, Pages (August 2011)
Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells  Yishai Avior, Elyad Lezmi, Dorit Yanuka, Nissim.
Volume 22, Issue 3, Pages (January 2018)
Lynnea R. Waters, Fasih M. Ahsan, Dane M
Volume 122, Issue 6, Pages (September 2005)
Volume 23, Issue 5, Pages (May 2016)
Volume 45, Issue 4, Pages (October 2016)
Volume 19, Issue 5, Pages (May 2017)
Volume 45, Issue 5, Pages (March 2012)
Volume 17, Issue 6, Pages (November 2016)
Volume 5, Issue 1, Pages e4 (July 2017)
Volume 13, Issue 9, Pages (December 2015)
Volume 24, Issue 6, Pages (December 2016)
Brandon Ho, Anastasia Baryshnikova, Grant W. Brown  Cell Systems 
Anthony T. Phan, Ananda W. Goldrath, Christopher K. Glass  Immunity 
Volume 2, Issue 3, Pages (March 2016)
Genome-wide Functional Analysis Reveals Factors Needed at the Transition Steps of Induced Reprogramming  Chao-Shun Yang, Kung-Yen Chang, Tariq M. Rana 
Circular RNA Transcriptomic Analysis of Primary Human Brain Microvascular Endothelial Cells Infected with Meningitic Escherichia coli  Ruicheng Yang,
Volume 25, Issue 5, Pages e4 (May 2017)
Presentation transcript:

Volume 42, Issue 3, Pages 419-430 (March 2015) Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization  Abhishek K. Jha, Stanley Ching-Cheng Huang, Alexey Sergushichev, Vicky Lampropoulou, Yulia Ivanova, Ekaterina Loginicheva, Karina Chmielewski, Kelly M. Stewart, Juliet Ashall, Bart Everts, Edward J. Pearce, Edward M. Driggers, Maxim N. Artyomov  Immunity  Volume 42, Issue 3, Pages 419-430 (March 2015) DOI: 10.1016/j.immuni.2015.02.005 Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 1 Integrated Metabolic-Transcriptional Profiling and Analysis Pipeline Cells derived from the same culture batch are grown in 96-well plates, stimulated, then lysed and processed in 96-well format to collect global metabolic and RNA-seq-based transcriptional profiles. Individual datasets are then processed and differential regulation data are mapped onto a global metabolic network that includes both enzymes and metabolites. Integrated network analysis then identifies the most coordinately responsive subnetwork and uncovers novel points of metabolic rewiring during macrophage polarization. Predictions of CoMBI-T profiling analysis are then validated mechanistically through labeling experiments and through the effects of targeted media perturbation and pharmacologic agents on cell phenotype. Immunity 2015 42, 419-430DOI: (10.1016/j.immuni.2015.02.005) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 2 Knowledge-Based Pathway Analysis of Metabolic and Transcriptional Data (A) Pathway analysis of enzymes that are transcriptionally upregulated in M1 or M2 states. Green bar points to the enzymes upregulated in M1 conditions (blue for M2) and corresponding enriched pathways are listed in the green box on the right (blue for M2). (B) Pathway enrichment analysis across metabolome profiling data shows KEGG pathways that are differentially regulated between all possible pairs of conditions (M1 versus M0, M2 versus M0, M1 versus M2). (C) Volcano plot shows metabolites differentially expressed between M1 and M2 conditions. x axis shows log-fold change between M1 and M2 conditions with positive values corresponding to metabolites upregulated in M1 macrophages. y axis shows p value for corresponding metabolite. Top M1-specific metabolites (itaconate and arginine) are highlighted in green, and top M2-specific metabolites are marked as red circles. Immunity 2015 42, 419-430DOI: (10.1016/j.immuni.2015.02.005) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 3 Major Metabolic Modules Are Rewired during Macrophage Polarization CoMBI-T reveals the most regulated subnetwork within global murine metabolic network that consists of more than 2,000 enzymes and metabolites measured through the CoMBI-T profiling pipeline. For comparison between M1- and M2-polarized macrophages, the most regulated metabolic subnetwork encompasses seven distinct modules highlighted by distinct background shading. Three major novel features of macrophage polarization identified by CoMBI-T are highlighted with dotted line squares—green for M1-specific module and red for M2. Round nodes represent metabolites within core regulatory network. Enzymes are represented by square nodes. Differential expression of corresponding enzyme/metabolite is indicated by the size of the node, and fold-change by red (M2) to green (M1) color scale. Enzymes in reactions with single product-substrate pair are represented by edges for visual convenience with thickness and color of the edge reflecting –log(p) and fold-change of differential expression correspondingly. For visual convenience, nodes of fatty acid synthesis module are not labeled. The complete metabolomic data used for CoMBI-T are available in Table S1. Immunity 2015 42, 419-430DOI: (10.1016/j.immuni.2015.02.005) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 4 Labeling and Pharmacological Inhibition Experiments Validate the Critical Role of UDP-GlcNAc Pathway in M2 Polarization (A) U-13C glucose (green outline) and U-13C (black outline), 15N2 (blue outline) glutamine were used as media for unstimulated/Il4-stimulated macrophages. Circle sizes are scaled with respect to pool sizes for individual metabolites in each condition. Exact labeling distributions and patterns are detailed in Table S2 for each metabolite. Thin black arrows represent known metabolic pathway connections; background arrows indicate deduced major metabolic flows in M2 macrophages. (B and C) Results of inhibition of N-glycosylation by tunicamycin: in the presence of the inhibitor, M2 commitment is significantly blocked by both Relmα (B) and CD206-CD301 staining (C). Immunity 2015 42, 419-430DOI: (10.1016/j.immuni.2015.02.005) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 5 Labeling and Media Perturbation Experiments Validate the Critical Role of Glutamine in M2 Polarization (A) Glutamine deprivation shows significant (∼50%) defect in M2 commitment in glutamine-deprived media based on CD301-CD206. (B) Relmα staining and Nos2 upregulation indicate a comparative lack of effect for glutamine deprivation on M1 versus M2 commitment. (C) Gene set enrichment analysis identifies significant transcriptional downregulation of TCA cycle. (D) Top 30 differentially expressed genes between M2 macrophages polarized in full media versus glutamine-deprived media. Corresponding p values are shown for glutamine-no glutamine M2 macrophages, genes that are statistically different between M0 and M2 macrophages are indicated in red. (E) Serum protein production of M2-specific chemokine CCL22 are downregulated when macrophages are polarized in glutamine-deprived conditions (error bars computed based on at least three independent experiments). Immunity 2015 42, 419-430DOI: (10.1016/j.immuni.2015.02.005) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 6 A Breakpoint in TCA Cycle Is a Major Metabolic Marker of Macrophage M1 Polarization Labeling data show that (iso)citrate labeled by glucose does not transfer carbon to AKG in M1 macrophages, consistently with transcriptional downregulation of Idh1, resulting in isocitrate-to-2-oxoglutarate (AKG) transition blocked in M1-activated macrophages. Immunity 2015 42, 419-430DOI: (10.1016/j.immuni.2015.02.005) Copyright © 2015 Elsevier Inc. Terms and Conditions

Figure 7 Labeling Data Reveal an Inflammatory Version of the Aspartate-Arginoscucinate Shunt in M1-Polarized Macrophages (A) U-13C glucose (green outline), U-13C (black outline), and 15N2-glutamine (blue outline) were used as media for unstimulated and M1-stimulated macrophages. Circle sizes are scaled with respect to pool sizes for individual metabolites in each condition. Exact labeling distributions and patterns are detailed in Table S2 for each metabolite. (B) Inhibition of Got1/2 (aspartate-aminotransferase, marked with lightning sign in A) with AOAA decreases nitric oxide and IL-6 production in a dose-dependent manner without affecting macrophage viability (Figure S3B) (error bars computed based on at least three independent experiments). (C) SeaHorse data on oxygen consumption rate (OCR) and extracellular acidification rates (ECAR), both rotenone and antimycin inhibited, and very high, compensatory M1 macrophages in which Got1/2 was inhibited, retain mitochondrial respiratory function (top), and exhibited ECARs similar to M0 macrophages (bottom). Immunity 2015 42, 419-430DOI: (10.1016/j.immuni.2015.02.005) Copyright © 2015 Elsevier Inc. Terms and Conditions